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Background: Stem cells can differentiate into multiple cell types, and therefore can be used for 
cellular therapies, including tissue repair. However, the participation of stem cells in tissue repair 
and neovascularization is not well understood. Therefore, implementing a noninvasive, long-term 
imaging technique to track stem cells in vivo is needed to obtain a better understanding of the 
wound healing response. Generally, we are interested in developing an imaging approach to track 
mesenchymal stem cells (MSCs) in vivo after delivery via a polyethylene glycol modified fibrin 
matrix (PEGylated fibrin matrix) using MSCs loaded with gold nanoparticles as nanotracers. The 
objective of the current study was to assess the effects of loading MSCs with gold nanoparticles 
on cellular function.
Methods: In this study, we utilized various gold nanoparticle formulations by varying size 
and surface coatings and assessed the efficiency of cell labeling using darkfield microscopy. 
We hypothesized that loading cells with gold nanotracers would not significantly alter cell 
f  unction due to the inert and biocompatible characteristics of gold. The effect of nanoparticle 
loading on cell viability and cytotoxicity was analyzed using a LIVE/DEAD stain and an MTT 
assay. The ability of MSCs to differentiate into adipocytes and osteocytes after nanoparticle load-
ing was also examined. In addition, nanoparticle loading and retention over time was assessed 
using inductively coupled plasma mass spectrometry (ICP-MS).
Conclusion: Our results demonstrate that loading MSCs with gold nanotracers does not alter 
cell function and, based on the ICP-MS results, long-term imaging and tracking of MSCs is 
feasible. These findings strengthen the possibility of imaging MSCs in vivo, such as with 
optical or photoacoustic imaging, to understand better the participation and role of MSCs in 
neovascularization.
Keywords: neovascularization, gold nanoparticles, cell tracking, stem cells, fibrin gel, optical 
imaging
Introduction
Stem cells are advantageous in that they can potentially be used for cellular therapies due 
to the fact that they can differentiate into multiple cell types,1 including cardiovascular 
cells.2–5 Previous work by our group demonstrated that PEGylated fibrin gels promote 
mesenchymal stem cell (MSC) tubulogenesis and differentiation towards a vascular cell 
type.4 These findings suggest MSCs could potentially be d  elivered to an injury site after 
an ischemic event in order to assist in neovascularization and tissue repair.3–7 However, 
the exact mechanisms of vascular repair, as well as the role and extent of participation 
of MSCs in neovascularization, are not well understood.
To this end, there have been numerous proposed approaches for long-term t  racking 
of stem cells in vivo. A majority of this research has focused on labeling MSCs in vitro, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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delivering the MSCs in vivo, and sacrificing the animals at 
various time points and performing histology.8 However, a 
major issue with this methodology is the inability to track the 
cells within a single, live animal model over time. As a result, 
many investigators have turned to noninvasive i  maging 
modalities which are capable of monitoring and tracking 
stem cells within a single model over time.9–11
The imaging approaches previously investigated require 
use of contrast agents to label the cells. Efficient cell labeling 
with contrast agents is necessary in order to image and track 
MSCs adequately. For long-term imaging, it is d  esirable 
to have contrast agents which have long-term stability, 
are not toxic to the cells, and do not affect cell function. 
R  adionuclides have short half-lives,12 and thus are not ideal 
for long-term imaging studies. Reporter genes indirectly 
label cells and are not diluted as a result of cell division.13 
However, the cells need to be genetically manipulated, which 
could alter cell function, and a substrate must be administered 
intravenously for each imaging session.13 Nanoparticles 
provide an advantage over radionuclides, in that they can be 
used for long-term imaging and allow for repeated imaging 
over time.12,14–17 Although nanoparticle labeling can decrease 
over time due to cell division, certain nanoparticle m  aterials, 
such as gold, are not toxic to the cells16 and do not alter cell 
function.
Taking into account the advantages and disadvantages 
of the various contrast agents which can be employed, we 
are interested in investigating gold nanoparticles to be used 
as contrast agents. We propose to use gold nanoparticles as 
contrast agents because of their optically tunable properties 
and inert characteristics. In addition, photoacoustic i  maging 
can be used to image cells labeled with gold   nanoparticles.18,19 
  Photoacoustic imaging can be used for in vivo imaging at 
reasonable depths,20 as well as for longitudinal studies.21,22 
  Specifically, the long-term goal of our study is to assess 
optically how MSCs delivered in vivo via a   PEGylated fibrin 
gel participate in the process of n  eovascularization. In this 
study, we assessed the efficiency of MSC labeling with gold 
nanotracers and the effects of nanoparticle loading on cell 
function. We determined initial nanoparticle loading and reten-
tion over time in order to assess the feasibility of long-term 
imaging of MSCs. This study provides a first step in achiev-
ing the goal of tracking the migration of MSCs delivered in 
vivo using PEGylated fibrin gels in order to assess the role of 
MSCs in the process of neovascularization and tissue repair. 
A better   understanding of the process of n  eovascularization, 
and the extent to which MSCs participate in this process, can 
potentially lead to the d  evelopment of better therapies and 
therapeutics, and s  pecifically therapies involving MSCs, for 
tissue repair.
Methods and materials
human Msc culture
Human MSCs (Lonza, Walkersville, MD) were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen, 
Carlsbad, CA) supplemented with 10% fetal bovine serum, 
1% glutamax, and 1% penicillin-streptomycin. The cell 
culture medium was changed every 2–3 days. Cells were 
passaged using 0.25% trypsin/ethylenediamine tetra-acetic 
acid (Lonza), collected by centrifugation at 600 × g for seven 
minutes, and counted with Trypan Blue exclusion. For all 
experiments, cells were seeded at a density of 5000 cells/cm2. 
Cells were grown under standard cell culture conditions 
(37°C, 5% CO2). P  assage 5–8 human MSCs were used in 
this study.
Nanoparticle synthesis
Gold nanoparticles were synthesized via citrate reduction 
of tetrachloroauric (III) acid (HAuCl4) under reflux. Briefly, 
100 mL of distilled water was heated to 100°C, and 1 mL of 
10 mg/mL HAuCl4 was added while stirring. Sodium citrate 
(11.4 mg/mL) dissolved in distilled water was then added. 
Gold nanoparticles of various sizes (20 nm, 40 nm, and 
60 nm) were synthesized by varying the volume of sodium 
citrate, ie, 2 mL of sodium citrate solution was added for 
20 nm nanoparticles, 1 mL of sodium citrate solution was 
added for 40 nm   nanoparticles, and 0.6 mL of sodium citrate 
s  olution was added for 60 nm nanoparticles. Gold nanopar-
ticles were coated with poly-L-lysine (1–5 kD) by adding 
0.3 mg of poly-L-lysine/mL of nanoparticle solution and 
allowed to mix for 30   minutes. The nanoparticles were then 
centrifuged at 3200 × g for 30 minutes in order to remove 
the excess poly-L-lysine.   Poly-L-lysine hydrobromide 
(Sigma-Aldrich, St. Louis, MO) was dissolved in distilled 
water prior to use.
Nanoparticle characterization
A DelsaNano (Beckman Coulter Inc, Brea, CA) was used 
to determine the size and zeta potential of citrate-stabilized 
and poly-L-lysine-coated gold nanoparticles in water and in 
media. Briefly, nanoparticle solutions were loaded into a glass 
cuvette and readings were taken at a temperature of 25°C. 
For size measurements, five repetitions were performed for 
each nanoparticle solution, with 60 readings per repetition. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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For zeta potential measurements, three repetitions were 
performed for each nanoparticle solution, with five readings 
per repetition.
A FEI Tecnai transmission electron microscope fitted 
with a top mount AMT Advantage HR 1k × 1k digital camera 
was used to determine the size and shape of citrate-stabilized 
and poly-L-lysine-coated gold nanoparticles in water and in 
media. Images were taken at 135k× magnification. Prior to 
imaging, carbon-coated copper 300 mesh grids (Electron 
Microscopy Sciences, Hatfield, PA) were placed in the 
n  anoparticle solutions and allowed to incubate for approxi-
mately two minutes. The grids were then removed from the 
solution and allowed to dry.
Nanoparticle incubation  
and assessment of cell uptake
Cells were cultured as described earlier. Nanoparticle medium 
was made by centrifuging the nanoparticle s  olutions (5000 × g 
for 15 minutes for 20 nm citrate-stabilized nanoparticles and 
3220 × g for 30 minutes for all other nanoparticle solutions) 
and resuspending the pellet in p  henol red free medium at 
a concentration of approximately 1012 n  anoparticles/mL. 
MSC growth medium was aspirated from the flasks, and 
200 µL/cm2 of nanoparticle medium was added to the cell 
culture and allowed to incubate for 24 hours. After 24 hours, 
the nanoparticle medium was removed and the cells were 
washed with phosphate-buffered saline. A Leica DMI2000B 
microscope equipped with a Leica DFC290 camera was used 
to obtain darkfield images (20× magnification) in order to 
assess nanoparticle uptake.
LIVe/DeAD staining
In order to assess cell viability after nanoparticle uptake, 
a LIVE/DEAD stain was performed. Briefly, stock solu-
tions of calcein AM (4 mM) and ethidium homodimer-1 
(2 mM) were diluted in phosphate-buffered saline to a final 
working concentration of 4 µM and 1 µM, respectively. 
MSC growth medium was removed from the wells, and 
the cells were washed twice in phosphate-buffered saline. 
The cells were then incubated in the LIVE/DEAD stain for 
45 minutes at 37°C, after which they were washed twice 
in phosphate-buffered saline. The stained cells were then 
imaged using fluorescence microscopy (Leica DMI2000B 
microscope equipped with a Leica DFC290 camera) under 
10× m  agnification. Control cells consisted of cells not 
incubated with nanoparticles. Cell viability was assessed at 
various time points over a two-week period.
MTT assay
A Sigma-Aldrich MTT cell proliferation assay kit was 
used to perform the MTT assay. Briefly, MTT reagent 
was added to cells at a ratio of 100 µL/mL of medium. 
The samples were incubated for three hours at 37°C. The 
detergent reagent was then used to lyse the cells. A uni-
versal microplate reader ELX800 (Bio-Tek Instruments 
Inc, Winooski, VT) was used to measure the absorbance 
values of the samples at 562 nm and a reference wavelength 
of 630 nm. Control cells consisted of cells not incubated 
with nanoparticles. A blank sample containing no cells 
was used and subtracted from all measurements. Cytotox-
icity was assessed over a one-week period at various time 
points. Triplicate samples were used and the assay was 
performed twice.
The number of cells was calculated using a standard 
curve. A one-way analysis of variance, followed by t-tests for 
multiple comparisons, was used to compare the e  xperimental 
conditions with the control condition at the same time point 
(P , 0.01).
Msc differentiation
The ability of the cells to exhibit bipotent proliferation 
(ie, adipogenic and osteogenic) after nanoparticle uptake 
was assessed for all nanoparticle conditions. Control cells 
consisted of cells not incubated with nanoparticles and which 
were induced to differentiate into the specified lineages. 
Negative control cells consisted of cells not incubated with 
nanoparticles and which were not induced to differentiate 
into the specified lineages.
Briefly, adipogenesis was induced by plating cells at a 
density of 2.1 × 104 cells/cm2 and allowing the cells to grow 
to confluence in MSC growth medium. After the c  ultures 
reached 100% confluence, the MSC growth medium was 
replaced with adipogenic induction medium (DMEM, 
10% fetal bovine serum, 1% penicillin-streptomycin, 1% 
  glutamax, 1 µM d  examethasone [Sigma-Aldrich], 10 µg/mL 
3-isobutyl-1-methylxanthine [Sigma-Aldrich], 10 µg/mL 
insulin [Sigma-Aldrich], and 100 µM indomethacin [Sigma-
Aldrich]). After three days, the adipogenic induction medium 
was replaced with adipogenic maintenance medium for 
one day (DMEM, 10% fetal bovine serum, 1% penicillin-
  streptomycin, 1% glutamax, and 10 µg/mL insulin). 
Three cycles of induction/maintenance were performed, after 
which the cells were incubated in adipogenic maintenance 
medium for seven days. Control cells were supplemented 
only with adipogenic m  aintenance medium. Oil red O International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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(Sigma-Aldrich) staining was used to assess adipogenesis. 
The cells were fixed in 10% f  ormalin and then incubated 
in 60% isopropanol for four m  inutes. The cells were then 
  incubated in oil red O s  taining solution for five minutes, 
rinsed in tap water, and c  ounterstained in hematoxylin for 
one minute. After w  ashing with tap water, the slides were 
mounted and viewed under phase contrast using a Leica 
DMI2000B microscope equipped with a Leica DFC290 
camera (20× magnification).
Osteogenesis was induced by plating cells at a density 
of 3.1 × 103 cells/cm2. The cells were allowed to adhere for 
24 hours in MSC growth medium, after which the medium 
was replaced with osteogenic induction medium (DMEM, 
10% fetal bovine serum, 1% penicillin-streptomycin, 1% 
glutamax, 50 µg/mL ascorbic acid, 100 nM d  examethasone 
[Sigma-Aldrich], and 10 mM beta-glycerophosphate 
d  isodium salt hydrate [Sigma-Aldrich]). Osteogenesis was 
induced over a period of two weeks, after which a Fisher 
von Kossa staining kit was used to assess osteogenesis. The 
cells were fixed in 10% formalin and then incubated in 5% 
silver nitrate for 40 minutes with exposure to ultraviolet light. 
The cells were washed in distilled water and then placed in 
5% sodium thiosulfate for two minutes, after which they 
were rinsed in tap water and placed in nuclear fast red stain 
for five minutes. After washing with tap water, the slides 
were mounted and viewed under brightfield using a Leica 
DMI2000B microscope equipped with a Leica DFC290 
camera (20× magnification).
Inductively coupled plasma mass  
spectrometry
Initial nanoparticle loading and retention over a two-week 
period was assessed for cells incubated with 20 nm citrate-
stabilized nanoparticles using inductively coupled plasma 
mass spectrometry (ICP-MS). Cells were cultured and incu-
bated with nanoparticles for 24 hours as described above. 
After 24 hours, the nanoparticle medium was removed and 
the cells were washed twice with phosphate-buffered saline. 
The cells were then incubated in MSC growth medium 
without nanoparticles and collected at the designated time 
points. Cell medium was changed every 2–3 days with MSC 
growth medium, and the cells were passaged after reaching 
about 80% confluence.
At the designated time points, the cells were collected, 
centrifuged, and resuspended in 300 µL of 70% nitric acid 
and incubated at 60°C for 14 hours, after which the cells 
were diluted 100× in distilled water. A standard curve was 
used to quantify the amount of gold in the cells. Briefly, 
standard solutions were made by diluting AAS gold standard 
(Sigma-Aldrich) in the same background solution as that 
of the cell solutions. All measurements were made using 
triplicate samples.
Results
Nanoparticle characterization
Nanoparticle size was analyzed using transmission electron 
microscopy (TEM) and dynamic light scattering (DLS). 
In addition, nanoparticle shape and zeta p  otential were 
assessed using TEM and DLS, respectively. Using DLS, 
the a  verage size of the three nanoparticle fo  rmulations 
(ie, citrate-stabilized nanoparticles in water) were 
determined to be 23.1 ± 4.14 nm, 49.78 ± 9.18 nm, and 
57.58 ± 10.72 nm (see Table 1), and were designated 
as 20 nm, 40 nm, and 60 nm, respectively. In addition, 
r  epresentative TEM images of 20 nm, 40 nm, and 60 nm 
citrate-stabilized nanoparticles in water are shown in 
F  igures 1A, 1B, and 1C, respectively.
Coating the gold nanoparticles with poly-L-lysine 
caused the zeta potential of the nanoparticles in water 
to go from negatively charged (approximately -30 mV) 
to positively charged (approximately +30 mV for 40 nm 
and 60 nm poly-L-lysine and +14 mV for 20 nm poly-
L-lysine), as determined using DelsaNano (results not 
shown). There was also a slight increase in the average 
size of the nanoparticles after coating with poly-L-lysine 
(see Table 1). It should be noted that 20 nm particles were 
most likely to undergo aggregation in the presence of 
poly-L-lysine, which may be attributed to cross-linking of 
nanoparticles by   poly-L-lysine. This effect is observed for 
the smaller p  articles because, as the size of the nanoparticle 
decreases, the relative concentration of nanoparticles/mL 
upon s  ynthesis increases as the third power of the ratio 
of nanoparticle diameters. As a result, a lower amount of 
poly-L-lysine per nanoparticle was added for the 20 nm 
particles compared with the 40 nm and 60 nm particles, 
which could result in insufficient coating of the smaller 
Table 1 Average nanoparticle diameter 
Average diameter
20 nm cs (water)   23.10 ± 4.14 nm
20 nm PLL (water) 1128.10 ± 226.64 nm
40 nm cs (water)   49.78 ± 9.18 nm
40 nm PLL (water)   52.02 ± 9.73 nm
60 nm cs (water)   57.58 ± 10.72 nm
60 nm PLL (water)   61.04 ± 11.65 nm
Notes: Dynamic light scattering was used to determine the average size of the nanoparticle 
formula  tions. Results are shown as average nanoparticle size ± standard error.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
411
Msc function after gold nanotracer loading
sized nanoparticles and thus formation of aggregates. To 
test this hypothesis, we varied the concentration of poly-L-
lysine used to coat 20 nm gold nanoparticles and found that 
increased poly-L-lysine concentration resulted in decreased 
nanoparticle a  ggregation (results not shown).
Msc nanoparticle loading
MSC nanoparticle loading was assessed using darkfield 
microscopy. Control cells were not incubated with nano-
particles and appear as a faint blue (Figure 2A). Due to the 
faint appearance of the control cells under darkfield, a phase 
contrast image of the control cells is provided in Figure 2A1 
to verify the presence of cells.
Nanoparticle-loaded cells appear a yellow-orange color 
when observed under darkfield microscopy, as compared 
with cells not loaded with nanoparticles, which appear 
blue. The darkfield images show that cells were loaded 
with 20 nm, 40 nm, and 60 nm citrate-stabilized nano-
particles after 24 hours of incubation (Figures 2B, 2D, 
and 2F, respectively), as evidenced by the yellow-orange 
appearance of the cells. In addition, cells were loaded 
with 20 nm, 40 nm, and 60 nm poly-L-lysine-coated 
nanoparticles after 24 hours of incubation (Figures 2C, 2E, 
and 2G,   respectively), as evidenced by the yellow-orange 
appearance of the cells.
Cells incubated with 20 nm, 40 nm, and 60 nm gold 
nanoparticles coated with polyethylene glycol did not exhibit 
nanoparticle uptake, as evidenced by the lack of yellow-
orange color of the cells (results not shown). Instead, cells 
incubated with polyethylene glycol coated nanoparticles 
(PEGylated nanoparticles) more closely resembled the 
control cells. However, MSC nanoparticle loading was not 
expected for cells incubated with PEGylated nanoparticles 
because of the well documented evidence for polyethylene 
glycol as a s  tealthing agent.23,24 Due to the fact that the nano-
particle formulations used in this study did not incorporate 
targeting agents (eg, targeting antibodies), nanoparticle 
uptake by cells was passive, and thus MSCs were unable to 
detect and passively uptake PEGylated nanoparticles.
Msc viability and cytotoxicity
MSC viability and cytotoxicity after nanoparticle loading was 
assessed using a LIVE/DEAD stain and an MTT assay. The 
effect of nanoparticle loading on MSC viability was assessed 
over a two-week period at various time points. The time 
points (day 1, day 7, and day 14) correspond to the number 
of days after initial nanoparticle incubation. The results of the 
LIVE/DEAD assay are shown in Figure 3A. Green cells were 
considered live and red cells were considered dead. Control 
cells were not incubated with nanoparticles. As evident from 
the representative LIVE/DEAD images in Figure 3A, the 
cells remained viable for all nanoparticle formulations over 
a two-week period, and there was minimal cell death present 
(indicated by white arrows).
Figure 2 Darkfield images (exposure time 257.3 msec) of mesenchymal stem cells incubated for 24 hours with B) 20 nm citrate-stabilized (cs), C) 20 nm poly-L-lysine (PLL),   
D) 40 nm citrate-stabilized, E) 40 nm poly-L-lysine, F) 60 nm citrate-stabilized, and G) 60 nm poly-L-lysine media. A) A control darkfield image and A1) phase-contrast image 
of mesenchymal stem cells not incubated with nanoparticles is shown for comparison. scale bars 100 µm.
AB C
Figure 1 Representative transmission electron microscope images of A) 20 nm, 
B) 40 nm, and C) 60 nm citrate-stabilized gold nanoparticles in water. scale bars 
100 nm.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Nanoparticle cytotoxicity was assessed at various time 
points over a one-week period using an MTT proliferation 
assay. The time points (day 1, day 4, and day 7) correspond 
to the number of days after initial nanoparticle incuba-
tion. The cell numbers were quantified using a spectro-
photometer and a standard curve. Control cells were not 
incubated with nanoparticles. The results for the MTT 
assay are shown in Figure 3B. It should be noted that the 
nanoparticles loaded within the cells did not contribute to 
the ultraviolet-visible spectrophotometry readings (results 
not shown). Cell numbers for the various nanoparticle 
formulations were statistically compared with the control 
condition for the corresponding day. It was found for day 
1 that cells loaded with 20 nm and 60 nm citrate-stabilized 
nanoparticles had a significantly lower cell number com-
pared with control cells (P , 0.01). In addition, on day 7, 
cells loaded with 60 nm poly-L-lysine nanoparticles had 
a significantly lower cell number compared with control 
cells (P , 0.01). It should be noted that some conditions 
(day 4, 60 nm citrate-stabilized, 20 nm poly-L-lysine, 
40 nm poly-L-lysine; day 7, 40 nm poly-L-lysine) had a 
significantly higher cell number compared with the control 
for the corresponding time point, the cause for which is 
not known at this time.
Msc differentiation
The bipotent ability of MSCs to differentiate into adipo-
genic and osteogenic lineages after nanoparticle loading 
was assessed in order to determine if MSC function was 
maintained after nanoparticle loading. Control (+) cells 
were not incubated with nanoparticles and were induced to 
differentiate, and control (-) cells were not incubated with 
nanoparticles and were not induced to differentiate.
Figure 4A shows the results of oil red O staining for 
assessing adipogenesis. Fatty lipid deposits were stained 
red (indicated by white arrows) and are indicative of adipo-
genesis. The ability of MSCs to differentiate into adipocytes 
was maintained for all nanoparticle formulations, as quali-
tatively assessed by comparing the control images with the 
nanoparticle-loaded MSC images. As expected, control (-) 
cells did not exhibit any lipid deposits, as indicated by the 
negative staining.
Figure 4B shows the results of von Kossa staining for 
assessing osteogenesis. Calcium deposits were stained black 
(indicated by red arrows) and are indicative of osteogenesis. 
The ability of MSCs to differentiate into osteocytes was 
maintained for all nanoparticle formulations, as qualita-
tively assessed by comparing the control images with the 
Figure  3  After  24  hours  of  incubation  with  nanoparticles,  the  particles  were 
removed and LIVe/DeAD and MTT assays were performed. A) Representative LIVe/
DeAD images of cells incubated with nanoparticles for 24 hours and assessed at 
various time points after nanoparticle removal over a two-week period. cells which 
appear green were considered live and those which appear red were considered 
dead (indicated by white arrows). scale bar 100 µm. B) An MTT assay was used 
to assess nanoparticle cytotoxicity by quantifying cell number over a one-week 
period using a plate reader at 562 nm. Data are shown as mean ± standard error. 
Significantly lower differences in cell number from the control for the corresponding 
day are indicated by an asterisk (P , 0.01).
Abbreviations: cs, citrate-stabilized; PLL, poly-L-lysine.
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A
B
Figure 4 The bipotent ability of mesenchymal stem cells to differentiate into adipogenic and osteogenic lineages was assessed after 24 hours of nanoparticle incubation. 
control cells were not incubated with nanoparticles. control (+) cells were induced to differentiate and control (-) cells were not induced to differentiate. A) Oil red O 
staining was used to assess adipogenic differentiation by staining for lipid deposits (white arrows). B) von Kossa staining was used to assess osteogenic differentiation by 
staining for calcium deposits (red arrows). scale bar 100 µm.
Abbreviations: cs, citrate-stabilized; PLL, poly-L-lysine.
nanoparticle-loaded MSC images. Control (-) cells did not 
exhibit any calcium deposits.
Msc nanoparticle uptake and retention
Initial nanoparticle loading and retention over a two-week 
period were determined for MSCs loaded with 20 nm 
citrate-stabilized gold nanoparticles using ICP-MS 
(see Figure 5A). The average number of nanoparticles/cell 
decreased by approximately an order of magnitude over a 
  two-week period from 4.53 × 105 ± 3.98 × 103   nanoparticles/cell 
to 2.00 × 104 ± 2.18 × 102 nanoparticles/cell. Also, the   number 
of nanoparticles/cell decreased exponentially over a 
two-week period. Figure 5B compares the average number of 
  nanoparticles/cell and cell proliferation rate for cells loaded 
with 20 nm citrate-stabilized nanoparticles. The data were 
normalized to the maximum value for the corresponding data 
set. Day 7 was the only data point that showed a significant 
difference between the ICP-MS and cell proliferation data 
(P , 0.01), as determined using a Student’s t-test.
Discussion
Previous work has demonstrated that PEGylated fibrin gels 
promote MSC differentiation and t  ubulogenesis.4 Many 
investigators have suggested delivering stem cells to an injury 
site (eg, myocardial infarction) in order to promote wound 
healing and retain normal physiological f  unction.2–4,25,26 
However, it is not clear if the MSCs implanted within the 
gels are actively participating in neovascularization in vivo, 
and, if so, what the specific role of the delivered MSCs is in 
neovascularization. Thus, we are proposing to load MSCs International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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with gold nanotracers in order to track and m  onitor the growth 
of MSCs over time in vivo after delivery. The specific aims 
of this study were to determine if nanoparticle loading of 
MSCs with gold nanotracers was possible, and to assess if 
MSC function was compromised as a result of nanoparticle 
loading. To this end, the results of this study demonstrate the 
feasibility of loading MSCs with gold nanotracers in order 
to track the MSCs in vivo. Specifically, MSCs were loaded 
with 20 nm, 40 nm, and 60 nm citrate-stabilized and poly-L-
lysine-coated gold nanoparticles (see Figure 1). In addition, 
nanoparticle loading was not cytotoxic to the cells and did 
not substantially affect MSC viability. MSC differentiation to 
adipogenic and osteogenic lineages was also maintained.
MSC nanoparticle loading was accomplished via pas-
sive uptake of the nanoparticles by the cells because no 
targeting agents were used to promote nanoparticle uptake. 
The nanoparticles aggregated when resuspended in cell 
culture medium, as evident from the change in color of the 
n  anoparticle solution from deep red to light blue, as well as 
the presence of peak broadening in the absorbance spectrum. 
Nanoparticle aggregation can most likely be attributed to the 
adsorption of serum proteins onto the nanoparticle surface. It 
is possible that protein adsorption could promote nanoparticle 
uptake by the cell.
It is interesting to note that the poly-L-lysine nanopar-
ticles did not have a negative effect on MSC function. Other 
investigators have found that high concentrations of poly-
L-lysine induce cell toxicity.27 However, poly-L-lysine is 
commonly used to coat substrates in low concentrations in 
order to promote cell adhesion, with no negative effects on 
cell viability. In this study, the cells were exposed to a low 
concentration of poly-L-lysine coating the nanoparticles, and, 
as a result, cell toxicity was not induced. In fact, p  revious 
investigators have also found that poly-L-lysine in low 
c  oncentrations, such as that used for coating nanoparticles, 
is not toxic to cells.28,29
The results of this study also demonstrate that nanopar-
ticle loading decreased exponentially over time. Previous 
investigators have cited the dilution of nanoparticle concentra-
tion per cell as a result of cell proliferation and division.15,30 
In addition, other investigators have suggested cell exocytosis 
of n  anoparticles may occur. The exocytosis process of cells 
loaded with gold nanoparticles has been quantified, with the 
exocytosis process dependent on nanoparticle size and shape, 
cell type, and extracellular environment.31,32 Taken together, 
these studies demonstrate that decreased nanoparticle l  oading 
over time could be attributed to cell division, as well as other 
mechanisms, such as exocytosis of the nanoparticles by the 
cells. The normalized data for the average number of nano-
particles/cell and the inverse of the cell number over time 
(see Figure 5B) exhibit a similar trend, with what appears 
to be an exponential decrease over time. If the decrease in 
nanoparticle retention over time was due only to cell division, 
we would not expect a significant difference between the ICP-
MS results and the cell proliferation data at the same time 
points. Of the three time points analyzed, only day 7 showed 
a   statistically s  ignificant difference between the ICP-MS and 
cell p  roliferation data. Thus, it was concluded that at the later 
time points, cell d  ivision was not the only factor responsible for 
the decrease in nanoparticle retention over time, and additional 
mechanisms, such as nanoparticle exocytosis, also significantly 
contributed to the observed results. However, as evidenced by 
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the results, a majority of the decrease in n  anoparticle retention 
over time was due to cell division.
Regardless of the mechanisms responsible for the 
decrease in the number of nanoparticles/cell, the decrease 
in nanoparticle retention over time has implications for 
the ability to image cells over long time periods. That is, 
a significant decrease in nanoparticle loading over time 
  corresponds to a substantial decrease in signal when i  maging. 
However, previous investigators have demonstrated the 
ability to use photoacoustic imaging, which is a noninvasive 
imaging approach that is capable of imaging cells at sufficient 
depths in vivo, to image human epithelial carcinoma cells.18 
The cells were also imaged in vitro and loaded with 50 nm 
epidermal growth factor receptor-targeted gold nanospheres 
almost an order of magnitude lower than that exhibited by 
MSCs after two weeks.18 Thus, we are confident that MSCs 
loaded with gold nanotracers can be detected and imaged over 
a two-week time period using photoacoustic imaging.
As mentioned previously, the end goal of this study is to 
develop an imaging technique which can visualize and track 
MSCs at sufficient depths and spatial/temporal resolutions. 
Specifically, we are interested in using a noninvasive i  maging 
approach which is capable of optically tracking MSCs in vivo 
over long time periods within a single animal model. Optical 
imaging modalities which could be employed to monitor and 
track MSCs include photoacoustic imaging,18,19 confocal 
microscopy,33 two-photon microscopy,34 and optical coher-
ence tomography.35,36
Conclusion
In summary, the work presented here demonstrates the a  bility 
to load MSCs with gold nanotracers of various sizes and 
surface coatings. In addition, this study also demonstrates 
that MSC function is not altered by nanoparticle loading. 
F  urthermore, these findings strengthen the possibility of 
imaging MSCs in vivo in order to understand better the 
participation and role of MSCs in neovascularization. The 
concentration of nanoparticle loading and retention over a 
two-week period suggests that long-term imaging and tracking 
of MSCs is feasible. Specifically, we are interested in develop-
ing an imaging approach to track MSCs in vivo after delivery 
via a PEGylated fibrin matrix using MSCs loaded with gold 
nanotracers. Thus, our future research will include in vitro 
imaging studies to verify that nanoparticle-loaded MSCs can 
be imaged using optical i  maging modalities (eg, photoacoustic 
imaging combined with ultrasound i  maging) and that MSC 
viability is not affected as a result of i  maging. In addition, 
in vivo studies are necessary to monitor the progression of 
MSC growth over time.
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